Cuatrecasas Cambra, G., De Cabo, F., Coves, M. J., Patrascioiu, I., Aguilar, G., Cuatrecasas Cambra, G., . . . Marron, E. M. (2024). Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity.
Citación estilo ChicagoCuatrecasas Cambra, Guillem, et al. Dapagliflozin Added to Metformin Reduces Perirenal Fat Layer in Type 2 Diabetic Patients With Obesity. 2024.
Cita MLACuatrecasas Cambra, Guillem, et al. Dapagliflozin Added to Metformin Reduces Perirenal Fat Layer in Type 2 Diabetic Patients With Obesity. 2024.
Precaución: Estas citas no son 100% exactas.